Tuesday, 22 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Finance
Clinical trial results
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14455
Articles
Company
Drug
Takeda’s Obizur Prioritized for Review in Acquired Hemophilia A Treatment
March 3, 2025
Company
Deals
Corestar Biotech Secures Series A Funding for POCT R&D Expansion
March 4, 2025
Company
Deals
Great Robotics Raises RMB 100M for Surgical Robot Development
March 4, 2025
Company
Deals
Visum Pharma Series B+ Financing to Advance R&D and GMP Workshop Construction
March 4, 2025
Company
Deals
Yunnan Jianzhijia Plans Acquisition of Hebei Tangren Pharmacy in USD 309 Million Deal
March 4, 2025
Policy / Regulatory
Sun Pharma Loses VBP Bid for Bicalutamide in China Due to Quality Failures
March 4, 2025
Company
Drug
Allist Pharmaceuticals’ Furmonertinib Receives NMPA Approval for First-Line NSCLC Treatment
March 4, 2025
Company
Deals
Dakang Medical Secures RMB 400M in Series E Round for Hemodialysis Center Expansion
March 4, 2025
Company
Drug
Ascentage Pharma’s APG-5918 Receives FDA Approval for First-in-Human Study
March 4, 2025
Company
Deals
Luzhu Bio Files for Hong Kong IPO After RMB 4.42 Billion Valuation
March 4, 2025
Company
Deals
Youwe Bio’s Series B Financing to Advance Microneedle Technology Commercialization
March 4, 2025
Policy / Regulatory
NHSA Updates NRDL with Focus on Expert Review and Simplified Renewals
March 4, 2025
1
2
…
1,188
1,189
1,190
1,191
1,192
…
1,204
1,205
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?